In focus · trending topic

BET Inhibitor

3 stories · following the connections

ConverGene Announces Sponsored Research Agreement with MD Anderson

By Nasdaq OMXSep 18, 2017, 11:00 AM UTC

ConverGene Announces Sponsored Research Agreement with University of Maryland, Baltimore to Evaluate First-in-class Anti-cancer Agents

By Nasdaq OMXJan 25, 2017, 3:18 PM UTC

ConverGene Announces a License Agreement With the National Center for Advancing Translational Sciences

By Nasdaq OMXDec 13, 2016, 9:15 PM UTC